Here are seven observations:
1. Titan Spine plans to make an impact in regenerative medicine through nanotechnology.
2. The company’s implants feature grooved surfaces, which encourage quick bone material production. Alternatively, smooth surfaces tend to foster fibrous tissue growth.
3. The nano-grooves are also designed to decrease inflammation and reduce recovery time.
4. The FDA recently approved Titan Spine’s nanotech device.
5. Titan Spine reported global sales of $33.5 million in 2015.
6. The company’s footprint extends to Germany and Spain.
7. The company hopes to grow 59 percent in 2016.
More articles on devices:
Globus Medical stock downgraded to “sell” by Goldman Sachs: 3 points
First Ray’s CortiClamp System receives FDA clearance: 4 takeaways
Stryker shares fall 0.81% — 4 notes on how the shares are faring
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
